|
|
|
September 10, 2009
Abbott Announces Acquisition of Evalve
Evalve was incorporated in 1999 to design, develop, manufacture, and market innovative devices to enable percutaneous repair of cardiac valves. The company's initial products are intended to reduce the risks, trauma and costs associated with current open, arrested heart surgical options. Abbott Laboratories recently announced its acquisition of Evalve. As the current owner of 10% of Evalve, Abbott will buy the remaining 90% for $320mn up front and $90mn in milestones. Read more here.
--------------------------------
Back to News
|
|
| |
